{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:25:50Z","timestamp":1783599950101,"version":"3.55.0"},"reference-count":65,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Nordic Studies on Alcohol and Drugs"],"abstract":"<jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To explore which drugs and intoxicants people most commonly seek information about from the Finnish AddictionLink online information service and to describe the types of the drug interaction questions submitted, the most frequently mentioned substances in the questions and the background characteristics of the questioners.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The study was conducted using data from the Finnish AddictionLink online information service. Medication-related questions submitted between 2011 and 2023 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1858) were extracted. Interaction-related questions (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 242) and the substances mentioned were categorized and analyzed. Background characteristics were described for individuals who submitted drug interaction-related questions (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 197) and for those who submitted other medication-related questions (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1070).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most questions concerned interactions between medications and intoxicants, with alcohol being the most frequently mentioned intoxicant, followed by stimulants and cannabis. Antidepressants were the most frequently mentioned drug class, followed by opioids, cardiovascular drugs, and benzodiazepines. Participants aged 13\u201325 years and those aged 46 years or older appeared to submit interaction-related questions more frequently, whereas individuals aged 26\u201345 were more likely to submit other medication-related questions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Questions concerning the concurrent use of medications with alcohol or illicit substances highlight a clear need for accessible and understandable information on drug\u2013intoxicant interactions. The frequent involvement of antidepressants and other commonly used medications underscores the relevance of these interactions in routine treatment. Increasing awareness among both healthcare professionals and medication users is essential to support safer treatment choices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/14550725261463002","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:57:02Z","timestamp":1783339022000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Questions on Medicines, Alcohol, and Illicit Drug Interactions in the Finnish AddictionLink Online Service: A Descriptive Analysis"],"prefix":"10.1177","author":[{"given":"Mari","family":"Vaarankorpi","sequence":"first","affiliation":[{"name":"University of Eastern Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-2647","authenticated-orcid":false,"given":"Ville","family":"Valkonen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland"},{"name":"Wellbeing Services County of North Savo, Hospital Pharmacy, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-3979","authenticated-orcid":false,"given":"Niina","family":"Karttunen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae094"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2019.1697283"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2020.09.006"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109715"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303061"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20054159"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-016-2044-y"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00726-4"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.24095\/hpcdp.42.2.01"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0190-x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2023.2223959"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.001651"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.05.001"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370505001013"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13152"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32229-9"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000524400"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.11.017"},{"key":"e_1_3_2_20_1","volume-title":"European drug report 2024","author":"European Union Drugs Agency","year":"2024","unstructured":"European Union Drugs Agency. (2024). European drug report 2024. Publications Office. https:\/\/data.europa.eu\/doi\/10.2810\/91693"},{"issue":"8","key":"e_1_3_2_21_1","first-page":"107","article-title":"Abuse and misuse of antidepressants","volume":"5","author":"Evans E. A.","year":"2014","unstructured":"Evans E. A., Sullivan M. A. (2014). Abuse and misuse of antidepressants. Substance Abuse and Rehabilitation, 5(8), 107\u2013120. https:\/\/doi.org\/10.2147\/SAR.S37917","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"3","key":"e_1_3_2_22_1","first-page":"171","article-title":"Can metronidazole cause a disulfiram-like reaction? A case-control study propensity matched by age, sex, and ethanol concentration","volume":"122","author":"Feldman R.","year":"2023","unstructured":"Feldman R., Jaszczenski R. (2023). Can metronidazole cause a disulfiram-like reaction? A case-control study propensity matched by age, sex, and ethanol concentration. WMJ: Official Publication of the State Medical Society of Wisconsin, 122(3), 171\u2013177. PMID: 37494646.","journal-title":"WMJ: Official Publication of the State Medical Society of Wisconsin"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108504"},{"key":"e_1_3_2_24_1","unstructured":"Finnish National Board on research integrity TENK. (2019). The ethical principles of research with human participants and ethical review in the human sciences in Finland. https:\/\/tenk.fi\/sites\/default\/files\/2021-01\/Ethical_review_in_human_sciences_2020.pdf"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-023-02444-w"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13852"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13060"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.09.010"},{"key":"e_1_3_2_29_1","unstructured":"Global status report on alcohol and health and treatment of substance use disorders. (2024). World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/9789240096745"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2013.07.2684"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.16993\/bbo.c"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13812"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14537"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017453"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019854958"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.141"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.02.014"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07035-6"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15398"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2195"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.643997"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051154"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108061"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1282831"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1434"},{"issue":"9","key":"e_1_3_2_46_1","first-page":"276","article-title":"Opioid pharmacokinetic drug-drug interactions","volume":"17","author":"Overholser B. R.","year":"2011","unstructured":"Overholser B. R., Foster D. R. (2011). Opioid pharmacokinetic drug-drug interactions. The American Journal of Managed Care, 17(9), 276\u2013287. PMID: 21999760","journal-title":"The American Journal of Managed Care"},{"issue":"7","key":"e_1_3_2_47_1","first-page":"601","article-title":"Pharmacokinetic drug-drug interaction and their implication in clinical management","volume":"18","author":"Palleria C.","year":"2013","unstructured":"Palleria C., Di Paolo A., Giofr\u00e8 C., Caglioti C., Leuzzi G., Siniscalchi A., De Sarro G., Gallelli L. (2013). Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of Research in Medical Sciences, 18(7), 601\u2013610. PMID: 24516494","journal-title":"Journal of Research in Medical Sciences"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190013504957"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2010.01.014"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20802"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109952"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01139-y"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103933"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06083-y"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8040073"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.6105"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13080897"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108713"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1576"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2018.79.799"},{"key":"e_1_3_2_61_1","doi-asserted-by":"crossref","unstructured":"United Nations Office on Drugs and Crime. (2024). World Drug Report 2024. UNODC. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html","DOI":"10.18356\/9789211065534"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000875"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-019-01091-0"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A066"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21073"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.033"}],"container-title":["Nordic Studies on Alcohol and Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14550725261463002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14550725261463002","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14550725261463002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:47:38Z","timestamp":1783597658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14550725261463002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":65,"alternative-id":["10.1177\/14550725261463002"],"URL":"https:\/\/doi.org\/10.1177\/14550725261463002","relation":{},"ISSN":["1455-0725","1458-6126"],"issn-type":[{"value":"1455-0725","type":"print"},{"value":"1458-6126","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"14550725261463002"}}